Drug intelligence / Profile preview

salvia chinensis

Development stage
Preclinical
Lead developer
Tianjiang Pharmaceutical
Administration
Oral, Topical
01

Overview

Salvia chinensis (Shi Jian Chuan) is a traditional Chinese medicinal herb classified as an "herb that invigorates the blood." It is used to stimulate blood circulation and is commonly indicated for conditions such as metrorrhagia, postmenstrual abdominal pain, amenorrhea, postpartum abdominal pain, arthralgia due to wind-dampness, various forms of cancer (including liver, stomach, colon, lung, esophageal and nasopharyngeal cancers), bone pain, abscesses and carbuncles. Additional uses include scrofula (lymph node tuberculosis), hepatitis and early-stage cirrhosis. The mechanism of action in TCM includes invigorating the blood flow and clearing heat/toxins; some modern studies suggest it may inhibit cancer cell growth. The plant's properties are described as bitter/acrid/bland in taste and cold or neutral in nature. It targets the heart, pericardium, lung, stomach liver spleen channels[1][2][4][5][6].

Other names
shi jian chuanchinese sage herbherba salviae chinensisred sage herb石见穿
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)CASP3 (Caspase-3)

Beyond the preview

Go deeper on salvia chinensis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salvia chinensis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call